Pharma Veterans

Women’s Health – The Untapped Opportunity – Asrar Qureshi’s Blog Post #1062 Dear Colleagues! This is Asrar Qureshi’s Blog Post #1062 for Pharma Veterans. Pharma Veterans Blogs are published by Asrar Qureshi on its dedicated site https://pharmaveterans.com. Please email to pharmaveterans2017@gmail.com for publishing your contributions here. Credit: Cnordic Nordic credit: MART Production Credit: Tima Miroshnichenko Credit: Yan Krukau This post is based on a McKinsey Report. Link at the end. Preamble Most top pharma companies derive more than 60 percent of their revenue from therapies for diseases that affect women uniquely, differently, or disproportionately. Despite significant strides in medicine, women's health remains an underexplored and underfunded sector. Many health concerns that disproportionately affect women are not sufficiently researched or addressed. Conditions such as endometriosis, polycystic ovary syndrome (PCOS), and various reproductive cancers receive a fraction o...

Understanding Women’s Health Gap – Asrar Qureshi’s Blog Post #995 Dear Colleagues! This is Asrar Qureshi’s Blog Post #995 for Pharma Veterans. Pharma Veterans Blogs are published by Asrar Qureshi on its dedicated site https://pharmaveterans.com. Please email to aq.pharmaveterans@gmail.com for publishing your contributions here. Credit: Cedric Fauntleroy Credit: Ivan Samkov Credit: Michelle Leman 26 August was Women’s Equality Day. Their health gap is a major challenge in achieving equality. Links of resources for this post at the end. Women live longer than men, but they spend 25 percent more of that time in poor health. Closing this gap can add more healthy years to their lives. It must be recognized that women’s health is not just a scaled down version of men’s health, but that it is biologically distinct and different. McKinsey Health Institute – MHI – in collaboration with World Economic Forum, has done detailed research and analysis on country-wise situation of women’s health, the...